ments; thin Mylar tape was used for the one window. Fluorescence was monitored in the direction normal to the incident x-ray beam in the horizontal plane. A single sample cell, extensively rinsed with an EDTA solution and deionized water between samples, was used for all the XRF measurements. Zn standards of 0, 0.5, 1.0, and 2.0 mM were prepared from a Zn atomic absorption standard solution (Sigma); solution volumes were measured gravimetrically. Data for the PKC 13I and control samples and the Zn standard solutions were accumulated for 5 min each at room temperature. Raw data in the form of fluorescence counts versus MCA channel number were converted to counts versus energy with the Cr K. peak (5.41 keV) and the scatter peak (11.2 keV) in a two-point linear calibration. Each of the energycalibrated spectra was interpolated onto an evenly spaced energy grid and normalized by the integrated counts in the scatter peak to correct for differences in total incident flux. Difference spectra were computed for the Zn 
. The availability of recombinant GM-CSF (2, 4, 5) has allowed a much fuller characterization of its activities, and it is now clear that GM-CSF stimulates a wide variety of hematopoietic and nonhematopoietic cell types (6) . As a therapeutic agent, GM-CSF has shown promise in the treatment ofaplastic anemia, myelodysplastic syndromes, acquired immune deficiency syndrome, neutropenias, and chemotherapy-induced myelosuppression (7, 8) . As a step toward understanding its structure-function rela-K. Diederichs (Table 1) so that despite the presence of the P sheet, GM-CSF can be compared with known four-helix bundle proteins (10) . The topology of the bundle places helices A and B, and helices C and D across the barrel from each other rather than next to each other.
This placement gives GM-CSF a double overhand topology (10) , which has previously been seen for porcine growth hormone (11) . Although interesting, the simi-430 from perfect alignment ( Table 1) .
For these reasons, the GM-CSF structure is clearly distinct from that of growth hormone and represents a novel fold. The topology of the GM-CSF fold as a whole is reminiscent of the -jellyroll member of the greek-key P-barrel family (12) , with four of the sheet strands replaced by helices (Fig.  iB) . Interestingly, the swirl of the GM-CSF jellyroll is left-handed, whereas all known A Fig. 1 (25) as described in the low-resolution structure determination (9) . Two additional heavy-atom derivatives were found (mersalyl acid and HgI2) that allowed better experimental phases to be determined. The multiple isomorphous replacement phases were refined by iterative solvent flattening (26) combined with noncrystallographic symmetry averaging (9) to yield a 3.5 A resolution averaged electron density map that showed the characteristic spiral of the a helices and density for many side chains. One of the helices showed three large side chains pointing into the protein core and could be fit by residues 99 to 116, which include three Phe residues. No other parts of the sequence could be recognized in the electron density. After three rounds of model building and simulated annealing refinement (27) with the use of partial models, the electron density improved so that the true amino acid sequence could be assigned to 3-jellyrolls are right-handed. The two disulfide bonds in GM-CSF are both at the same end of the molecule and connect helix B to strand 2 of the l sheet and helix C to the carboxyl terminus, respectively. Although there are no topological loop crossings, the loop from residues 43 to 54 penetrates the macrocycle formed by the carboxyl-terminal disulfide (Cys88-Cys'21) to result in a rare "threaded" topology (13) . A conserved proline-rich sequence (residues 89 to 94; Fig.  2 ) adopts an extended conformation and makes key hydrogen bonds to stabilize the threaded interaction: the carbonyl of Pro92 hydrogen bonds to the amide of Cys54 and the carboxylate of Glu93 hydrogen bonds to amides of both Glu56 and Thrs7 at the amino terminus of helix B.
Another notable feature of the fold is a stretch of 310 helix from residues 68 to 73.
The Pro76 residue interrupts the helical hydrogen-bonding pattern and causes a 300
bend in the chain leading into helix C. Since
Pro76 is not conserved across species (Fig.   2 ), it is unclear whether the bend is also present in murine GM-CSF or whether helix C might be longer. The solvent accessibility ofeach residue in GM-CSF (Fig. 2) is useful for distinguishing those residues that contribute to structural integrity from those that may be directly involved in receptor recognition. We can use the GM-CSF structure to show that many mutation studies aimed at characterizing structure-function relations for GM-CSF have been effective at locating structurally important regions rather than the receptor recognition site. A study of mutants in which various tripeptide deletions were made identified four regions in murine GM-CSF that were essential for activity (residues 18 to 22, 37 to 44, 54 to 64, and (24) . The gap in murine GM-CSF is placed so as to least disrupt the path of the chain. 96 to 118; human numbering) (14) . These four regions correspond to helix A, strand 1, helix B, and a stretch including P3 strand 2 and helix D (Fig. 2) . These regions are all likely to be critical for structural reasons With residues 21 to 31 of murine GM-CSF replaced by the human counterpart, the hybrid no longer binds to the murine receptor, and the hybrid with residues 78 to 94 of human GM-CSF replaced by the murine sequence no longer binds to the human receptor. Because residues 88 to 94 are conserved between murine and human GM-CSF, the second implicated region can be redefined as 78 to 87. Two further constructs pointed to the importance of Arg23 or Arg"' or both, because an Arg23 to Ghn mutant of human GM-CSF showed a 75% loss in specific activity and because inserting an Arg-Arg-Leu tripeptide after residue 22 of murine GM-CSF (which puts it in registry with the human sequence) decreased its activity by 98%. Further evidence consistent with the importance of residues 21 to 31 is the observation that deglycosylation of Asn27, which is adjacent to Areg' on the surface of GM-CSF (Fig. 3) , and Asn37 gives a 20-fold increase in the specific activity ofGM-CSF (18), as ifone or both of the carbohydrate groups interfere with receptor binding.
Although some of the results seen for the hybrid proteins may be indirect effects due to chang in protein conformation, it is interesting that residues 21 to 31 and 78 to 87 are mostly in helix A and helix C, which are neighbors in the helical bundle (Fig. 1) . Residue 76 is spatially adjacent to residue 21, but as the helices are antiparallel, the two stretches of residues diverge from each other so that residue 87 is 35 A from residue 31. Focusing on those implicated residues that are near each other allows us to present a putative receptor's view of the surface of GM-CSF centering on Arg' andMet'9 ( Fig.   3 ). Ala18, Glyfs, Pro76, and Met'9 form a hydrophobic patch surrounded by the polar side chains of Glu14, Asn7, Glu2, Arg24, Lys72 Lys 74 Thr'8, Ser82, and G1n86. That residues 1 to 16 and the turn at 67 to 70 are not important for activity suggests the recognition site stops before Glu14 and does not extend above Lys72. In addition to accounting for the available data, this proposed receptor recognition site also meshes nicely with ideas on protein-protein recognition, which suggest that hydrophobic groups are present to give strength to the interaction and hydrophilic groups to give the required specificity (19) . Methodical mutagenesis of these surface residues should allow further delineation of the receptor recognition site or sites, and if receptor binding can truly be localized to residues from these two segments alone, it gives a reasonable hope that synthetic mimics of this surface may be developed.
The high-affinity (dissociation constant Kd = 30 pM) GM-CSF receptor on hematopoietic cells, which is formed when the 80-kD receptor combines with a 120-kD chain (20) , has recently been shown to be a member of a family of structurally related receptors that indudes the receptors for interleukin-2 and growth hormone (21 ogous structures and thus apparently have evolved their receptor binding activities independently. The one thing that appears common to these structures is the high helical content and the use of residues in a helices for receptor binding.
Note added in proof The secondary structure and topology of the cytokine interleukin-4 have been determined by nuclear magnetic resonance studies and it appears to have the same fold as GM-CSF (32).
The goal of islet transplantation in human diabetes is to maintain the islet grafts in the recipients without the use of immunosuppression. One approach is to encapsulate the donor islets in permselective membranes. Hollow fibers fabricated from an acrylic copolymer were used to encapsulate small numbers of rat islets that were immobilized in an alginate hydrogel for transplantation in diabetic mice. The fibers were biocompatible, prevented rejection, and maintained normoglycemia when transplanted intraperitoneally; hyperglycemia returned when the fibers were removed at 60 days. Normoglycemia was also maintained by subcutaneous implants that had an appropriately constructed outer surface on the fibers. (2) . The capsules were insufficiently stable and biocompatible, a large volume of encapsulated islets was needed to achieve normoglycemia, and all of the encapsulated material could not be removed at the end of the experiments (3). Modifications in the encapsulation procedure have improved the biocompatibility of the membranes by covering the poly(L-lysine) envelope with an outer layer of alginate (4) . An intravascular device that separates the islets from the blood stream by permselective membranes was developed (5), but blood coagulated in the vascular lumen. An improved intravascular device maintained normoglycemia for several months in diabetic canines that had been implanted with two devices that contained canine islets (6) .
Hollow fibers formed of poly(acrylonitrile-co-vinyl chloride) (Amicon XM50) have been used for encapsulation ofneonatal mouse islet cells before transplantation into diabetic hamsters and for encapsulation and transplantation of human insulinoma cells into rats (7) . The encapsulated islet tissue was transplanted into the abdominal cavity, and in each of the two studies prolongation of survival of the islet xenografts was obtained in a few animals. Studies of the biocompatibility of these fibers have revealed a slight glial reaction when implanted into the brain of rats and only one to two layers of fibroblasts surrounded by collagen in mice when implanted intraperitoneally (8) .
We studied two types of acrylic copolymer hollow fibers to determine their efficacy in achieving normoglycemia when used for encapsulation of Wistar-Furth rat islets. Type 1 and type 2 fibers were identical except for their outer surface wall. Type 1 had a totally fenestrated outer wall, whereas type 2 fibers had a smooth outer surface (Fig. 1) 
